TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules) is disappointed in the decision made by the US Food and Drug Administration (USFDA) to request […]
Category Archives: Pr Newswire
Pr Newswire
ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
10
Aug
Aug
KEY HIGHLIGHTS Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease on track to begin H2-2024. Obesity with related metabolic complications selected as lead indication for Inflammasome ASC Inhibitor IC 100. Supportive data from preclinical study in atherosclerosis, a common obesity-related metabolic complication, is expected to be available H2-2024. […]
10
Aug
Aug
Advancement of clinical and regulatory steps enable the expected initiation of Phase 2 obesity clinical trial for nimacimab peripheral CB1 inhibitor in Q3 2024 SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (NASDAQ: SKYE) (“Skye” or the “Company”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today […]
10
Aug
Aug
CAMBRIDGE, Mass., Aug. 09, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to four new employees. Fulcrum granted stock options to purchase shares of the […]
10
Aug
Aug
Tinlarebant, a novel oral therapy, is intended to slow disease progression in patients affected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related Macular Degeneration (Dry AMD) Phase 1b & 2/3 (“DRAGON II”) trial of Tinlarebant in adolescent STGD1 patients has been initiated and have completed enrollment for Phase 1b with six […]
HOUSTON, Aug. 10, 2024 /PRNewswire/ — On August 8, 2024, SEG Solar (SEG), a leading U.S. photovoltaic manufacturer, held a grand opening ceremony for its new PV manufacturing base in Houston, Texas, marking a new chapter in SEG’s commitment to U.S. domestic manufacturing. During the ceremony, the first 585W YUKON N series module rolled off the […]
Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing strong performance across key segments. Focused on Innovation and Efficiency: Investing […]
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Global IBO Group Ltd. (“GIBO”), a unique and integrated AIGC animation creation and streaming platform for storytellers and content creators, and Bukit Jalil Global Acquisition 1 Ltd. (“Bukit Jalil Global”) (Nasdaq: BUJA), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive […]
LONDON and NEW YORK, Aug. 9, 2024 /PRNewswire/ — Today, i2 Group said increasing demand for its intelligence analytics software among NATO forces and intelligence and law enforcement agencies was driving the company’s double-digit growth. The global leader in visual data analysis today reported an annual 18% uptick in software license sales and 10% workforce growth as […]
BEIJING, Aug. 9, 2024 /PRNewswire/ — Power Construction Corporation of China (“POWERCHINA” or “the Company”) continues to do its part to alleviate the harsh summer climate change challenges affecting many regions worldwide. The Company’s series of construction projects and actions have enhanced the flood control and drought resistance capabilities of various regions in Americas, Africa, and Asia, […]